Publication Month: Jan 2019 | Report Code: TIPHE100001112 | No. of Pages: 186 | Category: Medical Device | Status: Published
Infusion pump is a device used to deliver liquids into a patient’s body in a regulated manner, the pump enables to deliver fluid in large and small amounts. The pump is used to deliver both nutrients and medication in the patient’s body. Infusion pumps are regularly used to administer critical fluids, including high-risk medications, pump failures can have significant implications for patient safety. The growth of the Infusion Pumps in healthcare market is attributed to the increasing incidence of chronic diseases, increasing number of surgical procedures performed and growing geriatric population. However, the market is likely to experience restraining factors such as frequent product recalls of infusion pumps and stringent regulatory requirements.
The Infusion Pumps in healthcare market is expected to witness substantial growth post-pandemic. The Infusion Pumps in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Get more information on this report :
An infusion pump, a medical device delivers fluids, like nutrients and medications, into a patient's body in precise amounts. Infusion pumps are widely used in hospitals, nursing homes, and some types of infusion pumps can be used at home too. Infusion pumps are used to deliver medications – such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Thus rising prevalence of chronic diseases like cancer, diabetes and others drives the market growth.
Diabetes is one of the largest global health emergencies of the 21st century. Each year more and more people live with this condition, which can result in life-changing complications. According to the International Diabetes Federation (IDF), in 2017, number of people with diabetes in North America was approximately 46 million which is expected to grow at 62 million in 2045. The increase in the disease prevalence is around 35% during the forecast period.
Also, according to the World Health Organization in 2018, cancer was the second leading cause of death across the globe, and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, the American Cancer Society estimated that in 2018, 1,735,350 new cancer cases were diagnosed in 2018.
Infusion pumps are also used to treat heart failure that helps in relieving and controlling the symptoms. According to Emory Healthcare in 2018, around 5 million people in America suffer from congestive heart failure (CHF).
Thus, the increasing incidences of chronic diseases poses several opportunities for the infusion pumps market to grow during the forecast period.
Infusion pumps are used during surgeries to send pain medicine through catheter to a specific part of your body. Infusion pumps can provide targeted and consistent medicine to decrease the pain. They are used when other methods are less effective or when the patient need long-term medicines or fluids.
The plastic surgical procedures like liposuction, abdominoplasty, and mammoplasty, require short hospital stay, patients are discharged for ambulatory recovery on oral analgesic management. However, anesthetists have started using infusion pumps to achieve adequate outpatient analgesic control. These pumps continuously administer and maintain constant plasma concentrations. According to the American Society of Plastic Surgeons in 2017, there were around 17.5 million surgical and minimally invasive plastic procedures performed in the United States.
Also, according to the Centers for Disease Control and Prevention (CDC) every year about 735,000 people in suffer from a heart attack. Furthermore, the Johns Hopkins University has estimated that approximately 84 million people in the US suffer from some form of the cardivascular disease. This has led to increase in cardiovascular surgeries.
Also, as per the survey “Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes” 312 million major surgical procedures were performed in 2012, an increase of one-third from 2004. The number of surgical procedures are increasing whereas the number of deaths are decreasing.
Thus, increasing number of surgical procedures coupled with technological advancements is anticipated to drive the infusion pumps market.
Infusion pumps are widely used in geriatric population as it is an improved method to administer medication/ hormone/ nutrition and others. For instance, diabetes is a major cause of morbidity and mortality in ageing population that later largely attributable to various chronic complications. The number of ageing people with diabetes is increasing due to increased lifespan and the increased prevalence of diabetes in the geriatric population in the United States and worldwide. Infusion pump for diabetes provides more flexibility to the patient’s lifestyle while giving them greater control of the disease.
The elderly population is defined as group of people aged 65 and over. Population ageing is poised to become one of the most significant social transformations of the twenty-first century. According to the report of United Nations, in 2017, there were approximately 962 million people aged 60 or over across the globe, that consists of 13% of the global population. The population aged 60 or above is growing at a rate of about 3 per cent per year. Across the globe, the number of persons aged 80 or above is projected to triple by 2050. The approximate population is around 137 million in 2017 which will reach up to 425 million in 2050. The value is expected to increase to 909 million in 2100, around seven times its value in 2017.
The elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the chronic diseases has increased. Therefore, the demand of infusion pumps products are expected to increase in the forecast period.
In terms of type, the Infusion Pumps in healthcare market is segmented into ambulatory pumps, volumetric pumps, syringe pumps and accessories. In 2017, the volumetric pumps segment held a largest market share of 48.6% of the infusion pumps market, by type. The segment is anticipated to witness growth at a substantial rate of 6.4% during the forecast period.
Get more information on this report :
Based on application, the Infusion Pumps in healthcare market is segmented into diabetes, chemotherapy, gastrointestinal diseases and pediatrics. In 2017, the chemotherapy segment held a largest market share of 36.4% of the infusion pumps market, by application.
In terms of end user, the Infusion Pumps in healthcare market is segmented into hospitals & clinics, ambulatory surgical centers and homecare. In 2017, the hospital segment held a largest market share of 45.5% of the infusion pumps market, by end user.
|Market Size Value in||US$ 11,378.8 Million in 2017|
|Market Size Value by||US$ 18,045.6 Million by 2025|
|Growth rate||CAGR of 6.2% from 2018-2025|
|No. of Pages||186|
|No. of Tables||97|
|No. of Charts & Figures||65|
|Historical data available||Yes|
|Segments covered||Type , By Application and End User and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The Infusion Pumps in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
o Enteral Pumps
o Patient-Controlled Analgesia (PCA) Pumps
o Insulin Pumps
O Smart Pumps
o Elastomeric Pumps